XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue        
Total revenue $ 12,598 $ 8,959 $ 39,175 $ 26,430
Cost of revenue 928 883 3,196 2,618
Gross profit 11,670 8,076 35,979 23,812
Operating expenses:        
Research and development 11,022 7,609 30,849 20,572
Sales and marketing 4,411 3,242 12,788 7,971
General and administrative 3,991 1,742 12,138 9,754
Total operating expenses 19,424 12,593 55,775 38,297
Loss from operations (7,754) (4,517) (19,796) (14,485)
Interest and other income (expense), net 318 (183) 346 (497)
Loss before provision for income taxes (7,436) (4,700) (19,450) (14,982)
Provision for income taxes 248 268 722 612
Net loss $ (7,684) $ (4,968) $ (20,172) $ (15,594)
Net loss per share attributable to common stockholders        
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.23) $ (0.24) $ (0.63) $ (0.79)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.23) $ (0.24) $ (0.63) $ (0.79)
Weighted average shares used in computing per share amounts        
Weighted average shares used in computing per share amounts, basic (in shares) 32,836,014 20,578,386 32,228,429 19,768,574
Weighted average shares used in computing per share amounts, diluted (in shares) 32,836,014 20,578,386 32,228,429 19,768,574
Licensing, support and maintenance        
Revenue        
Total revenue $ 11,135 $ 8,136 $ 35,743 $ 24,353
Variable royalties and other        
Revenue        
Total revenue $ 1,463 $ 823 $ 3,432 $ 2,077